EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Oral Microbiota, Microbial Metabolites, and Immuno-Inflammatory Mechanisms in Cardiovascular Disease

Zheng Wang iD, Robert C Kaplan, Robert D Burk, Qibin Qi

International Journal of Molecular Sciences · 17.11.2024 · 25 (22) · 12337

DOI: 10.3390/ijms252212337 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 17.11.2024. Verfasst von Zheng Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY 10461, USA. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Mouth. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 136 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, National Heart, Lung, and Blood Institute (NHLBI).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cardiovascular diseases (CVDs) remain a leading cause of global morbidity and mortality. Recent advancements in high-throughput omics techniques have enhanced our understanding of the human microbiome’s role in the development of CVDs. Although the relationship between the gut microbiome and CVDs has attracted considerable research attention and has been rapidly evolving in recent years, the role of the oral microbiome remains less understood, with most prior studies focusing on periodontitis-related pathogens. In this review, we summarized previously reported associations between the oral microbiome and CVD, highlighting known CVD-associated taxa such as Porphyromonas gingivalis, Fusobacterium nucleatum, and Aggregatibacter actinomycetemcomitans. We also discussed the interactions between the oral and gut microbes. The potential mechanisms by which the oral microbiota can influence CVD development include oral and systemic inflammation, immune responses, cytokine release, translocation of oral bacteria into the bloodstream, and the impact of microbial-related products such as microbial metabolites (e.g., short-chain fatty acids [SCFAs], trimethylamine oxide [TMAO], hydrogen sulfide [H2S], nitric oxide [NO]) and specific toxins (e.g., lipopolysaccharide [LPS], leukotoxin [LtxA]). The processes driven by these mechanisms may contribute to atherosclerosis, endothelial dysfunction, and other cardiovascular pathologies. Integrated multi-omics methodologies, along with large-scale longitudinal population studies and intervention studies, will facilitate a deeper understanding of the metabolic and functional roles of the oral microbiome in cardiovascular health. This fundamental knowledge will support the development of targeted interventions and effective therapies to prevent or reduce the progression from cardiovascular risk to clinical CVD events.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiovascular DiseasesMouthHumansInflammationGastrointestinal MicrobiomeMicrobiotaAnimals

Stichwörter der Autor:innen

cardiovascular diseasesgut microbiomeinflammatory markersmicrobial metabolitesoral microbiome

Autor:innen und Institutionen

  • Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
  • Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
  • Department of Obstetrics & Gynecology and Women's Health, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
  • Department of Microbiology & Immunology, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
  • Department of Pediatrics, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
  • Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA.

ORCID-Profile: Zheng Wang

Förderung

  • NHLBI NIH HHS
  • National Heart, Lung, and Blood Institute (NHLBI)

Zitieren

APA

Wang, Z., Kaplan, R. C., Burk, R. D., & Qi, Q. (2024). The Oral Microbiota, Microbial Metabolites, and Immuno-Inflammatory Mechanisms in Cardiovascular Disease. International Journal of Molecular Sciences, 25(22), 12337. https://doi.org/10.3390/ijms252212337

Vancouver

Wang Z, Kaplan RC, Burk RD, Qi Q. The Oral Microbiota, Microbial Metabolites, and Immuno-Inflammatory Mechanisms in Cardiovascular Disease. International Journal of Molecular Sciences. 2024;25(22):12337. doi:10.3390/ijms252212337

BibTeX
@article{Wang2024,
  author = {Wang, Zheng and Kaplan, Robert C and Burk, Robert D and Qi, Qibin},
  title = {The Oral Microbiota, Microbial Metabolites, and Immuno-Inflammatory Mechanisms in Cardiovascular Disease},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {22},
  pages = {12337},
  doi = {10.3390/ijms252212337}
}
Kostenlos starten →